Mission Statement

The mission of the Wyoming State Board of Pharmacy is to promote and protect the health and safety of the public by regulating the practice of pharmacy.

Recent Announcements

The Wyoming State Board of Pharmacy will meet on December 8-9, 2021 in Extension Room 5 of the Wyoming State Capitol. The Capitol is located at 200 W 24th St in Cheyenne. Wyoming does not have a statewide mask mandate, but some businesses may require masks. Based on the CDC’s guidelines, in order to maximize protection for participants and prevent possibly spreading COVID to others, participants are encouraged to wear a mask, even if fully vaccinated. Participants may also attend the meeting virtually by using the following Google Meeting ID: meet.google.com/jvj-xuaj-ycc or by calling 1 520-800-2794 PIN: 888 274 220#

Pharmacist and Pharmacy Technician Renewals

The Board office will be mailing renewal notices out to pharmacists and pharmacy technicians on October 29, 2021. Online renewals are open now. For more information on how to renew online, please review this document.

On October 12, 2021, the U.S. Food and Drug Administration announced that it intends to withdraw, effective Dec. 31, 2021, guidances originally issued in March 2020 outlining temporary policies for manufacturers that were not drug manufacturers at the time to produce certain alcohol-based hand sanitizer and alcohol for use in hand sanitizers during the public health emergency.

For more information please refer to the FDA's announcement.

WPAP Healthcare Provider Support Group

The Wyoming Professional Assistance Program will be reinstating its weekly confidential support group meeting for healthcare providers coping with burnout, PTSD and stress related to treating COVID-19. Every Thursday at 6:30 PM Mountain Time

Join Zoom Meeting


Meeting ID: 868 9748 7256

Dial in

+1 669 900 6833

Meeting ID: 868 9748 7256

Issuing and Dispensing Prescriptions for Controlled Substances in 2021

As a reminder, pursuant to Wyoming Statute 35-7-1030, controlled substances are now required to be electronically prescribed. The requirements for electronic prescribing systems and exemptions to the electronic prescribing requirement can be found in the Wyoming Controlled Substances Act Rules Chapter 10.

Distribution of controlled substances

It is the Board’s understanding that many resident pharmacies have been distributing controlled substances to practitioners for office dispensing. While the Board does not prohibit this practice, there are many requirements that should be followed in order for pharmacies to be compliant with federal law.

The Board strongly encourages all licensees that may be engaged in this activity to review their current processes to ensure compliance with state and federal law. The following federal provisions are being provided to aid in that review. As a reminder, the Board’s rules and DEA regulations prohibit prescriptions from being issued in order for practitioners to obtain controlled substances for supplying the practitioner for the purpose of general dispensing to patients.

  • 21CFR1304.22 - Records for manufacturers, distributors, dispensers, researchers, importers, exporters, registrants that reverse distribute, and collectors

  • 21CFR1305.03 - Distributions requiring a Form 222 or a digitally signed electronic order

  • 21CFR1305.06 - Persons entitled to fill orders for C-I and C-II substances

  • 21CFR1307.11 - Distribution by dispenser to another practitioner

The Board would like to remind all pharmacies that if they are engaged in this practice, it would be considered distribution. Licensees should not be reporting the distribution of controlled substances as prescriptions into the Wyoming Online Prescription Database (WORx). Please direct any questions to the Board office in writing to bop@wyo.gov.

Butalbital Schedule Status in Wyoming

It has come to the Board's attention that there are questions surrounding butalbital scheduling. The Wyoming Controlled Substances Act (Wyoming Statute 35-7-1018(c)(iii)) lists “any substance which contains any quantity of a derivative of barbituric acid or any salt thereof" as a schedule III-controlled substance. While there are butalbital products listed on the DEA’s list of Exempted Prescription Products, including Fioricet (butalbital/acetaminophen/caffeine), Wyoming does not have a similar list of exempted products. All butalbital-containing products, therefore, are schedule III-controlled substances in Wyoming and must be treated as such.

1712 Carey Ave. Ste 200 Cheyenne, WY 82002

Phone: 307-634-9636 Fax: 307-634-6335